Clinical Trials Browser

Phase 1 × Has results × talimogene laherparepvec × Clear all

NCT03663712 2024-11-20

TEMPO

Phase 1 Completed

28 enrolled 10 charts

Peritoneal Neoplasms

NCT03300544 2024-05-23

Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer

Phase 1 Terminated

3 enrolled 9 charts

Gastrointestinal

Rectal Neoplasms

NCT03256344 2024-05-14

Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases

Phase 1 Completed

36 enrolled 16 charts

BreastGastrointestinal

Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT02756845 2024-02-20

Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors

Phase 1 Completed

15 enrolled 13 charts

Advanced Non CNS Tumors

NCT02626000 2021-09-08

MASTERKEY232

Phase 1 Completed

36 enrolled 18 charts

Squamous Cell Carcinoma of Head and Neck

NCT00402025 2016-04-15

Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer

Phase 1 Completed

17 enrolled 14 charts

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms